// company-profile

Dermata Therapeutics, Inc.

DRMA
ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings41Insiders11
// api This Dermata Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bearish. Over the last 30 days, insiders net sold $13 across 1 transaction.

// 90-day insight

Over the last 90 days, Dermata Therapeutics, Inc. insiders sold $13 across 1 transaction with no open-market purchases.

  • Most active insider: Scott Kathleen D. with 1 transaction totaling $13.
  • Largest single sale: $13 by Scott Kathleen D. on Jun 16, 2026.

Activity skews bearish — sales outpace buys.

Institutional Ownership

Top 13F-HR holders of Dermata Therapeutics, Inc. as of 2026-03-31

— stable
Total reported AUM
$128,853
QoQ change
Reporting period
2026-03-31
#1
GEODE CAPITAL MANAGEMENT, LLC
CIK 1214717
$58,370
48K shares
#2
UBS Group AG
CIK 1610520
$29,324
24K shares
#3
Welch & Forbes LLC
CIK 105495
$24,200
20K shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 16, 2026Scott Kathleen D.DRMA
Sale
11$1.19$0K
Feb 17, 2026Bedoya-Toro Munera Maria EDRMA
Purchase
1,000$1.27$1K
Jan 2, 2026HALE DAVID FDRMA
Award
2,500$0.00$0K
Jan 2, 2026Bedoya-Toro Munera Maria EDRMA
Award
9,000$0.00$0K
Jan 2, 2026Bradrick BrittanyDRMA
Award
2,500$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.